Semtech shares still soaring after Q2 earnings report
Shares of Camarillo-based Semtech climbed nearly 10% after a strong earnings report on Sept. 1, and in the following week continued to trade at their highest levels since February. Semtech, a semiconductor company specializing in Internet of Things applications, closed at $77.50 on Sept. 7. That was 9% above its closing price of $71.13 on Read More →
Hair care company with UCSB roots plans IPO
Olaplex, a hair care products company founded in Santa Barbara using technology developed by UCSB chemists, is planning an initial public stock offering. The company filed a prospectus with the U.S. Securities and Exchange Commission on Aug. 27, but the filing gave no details on the price of the shares, the number of shares to Read More →
Semtech shares up after strong earnings report
Semtech Corp., a Camarillo semiconductor company specializing in Internet of Things applications, saw shares up more than 5% after the markets closed Sept. 1 after the company shared a record-breaking financial statement for the second quarter of fiscal year 2021-22. Semtech delivered earnings of $32.2 million, or 50 cents per share, for the second quarter Read More →
QAD reports loss as $2B acquisition nears
QAD, a Santa Barbara-based cloud software company for the manufacturing industry, saw its revenue and expenses rise in the second quarter of 2021 as the company prepares to be bought out by a San Francisco-based private equity firm. QAD lost $6.3 million, or 31 cents per share, in the quarter ended July 31, the company Read More →
Teledyne Chairman Mehrabian will step back into CEO’s office
Teledyne Technologies Chairman Robert Mehrabian, who spent two decades as the company’s CEO, will step back into that post when Teledyne’s current CEO, Al Pichelli, retires on Oct. 15. Mehrabian is Pichelli’s predecessor as well as his successor — Pichelli took over as CEO on Jan. 1, 2019 when Mehrabian stepped down. Mehrabian was president Read More →
Arcutis starts new Phase 3 trial
Arcutis Biotherapeutics announced Aug. 25 that it has enrolled the first patient in a Phase 3 clinical trial to evaluate ARQ-154, its topical foam, as a treatment for scalp and body psoriasis. The foam is a once-daily formulation of roflumilast, a phosphodiesterase type 4 inhibitor that the company is developing to treat two skin conditions: Read More →
Limoneira predicts earnings growth despite drought and supply chain woes
Santa Paula-based agribusiness Limoneira released preliminary financial results on Aug. 24 for its most recent quarter, highlighting strong fresh lemon utilization which helped offset a smaller-than-expected avocado output. Limoneria said it expects revenue of $49 million in the third quarter of 2021, which would be a slight decrease from the same quarter a year ago, Read More →
